BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2184486)

  • 1. [Neuroleptic malignant-like syndrome following levodopa withdrawal].
    Rascol O; Salachas F; Montastruc JL
    Rev Neurol (Paris); 1990; 146(3):215-8. PubMed ID: 2184486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apomorphine in malignant syndrome due to levodopa withdrawal.
    Bonuccelli U; Piccini P; Corsini GU; Muratorio A
    Ital J Neurol Sci; 1992 Mar; 13(2):169-70. PubMed ID: 1592579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome without neuroleptics.
    Ong KC; Chew EL; Ong YY
    Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome without neuroleptics.
    Parsa MA; Rohr T; Ramirez LF; Meltzer HY
    J Clin Psychopharmacol; 1990 Dec; 10(6):437-8. PubMed ID: 2286714
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of levodopa-induced myoclonus and levodopa withdrawal-induced neuroleptic malignant syndrome. A case report.
    Hirschorn KA; Greenberg HS
    Clin Neuropharmacol; 1988 Jun; 11(3):278-81. PubMed ID: 3401861
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome in Parkinson's disease after withdrawal or alteration of dopaminergic therapy.
    Keyser DL; Rodnitzky RL
    Arch Intern Med; 1991 Apr; 151(4):794-6. PubMed ID: 1672810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal.
    Friedman JH; Feinberg SS; Feldman RG
    JAMA; 1985 Nov; 254(19):2792-5. PubMed ID: 4057489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome without withdrawal of levodopa.
    Singla R; Singla A; Kumar S; Kar P
    Natl Med J India; 2009; 22(3):162. PubMed ID: 19764697
    [No Abstract]   [Full Text] [Related]  

  • 9. Levodopa withdrawal syndrome identical to neuroleptic malignant syndrome.
    Gibb WR; Griffith DN
    Postgrad Med J; 1986 Jan; 62(723):59-60. PubMed ID: 3797365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance.
    Ladha SS; Walker R; Shill HA
    Mov Disord; 2005 May; 20(5):630-1. PubMed ID: 15719433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. It was not just a heatwave! Neuroleptic malignant-like syndrome in a patient with Parkinson's disease.
    Douglas A; Morris J
    Age Ageing; 2006 Nov; 35(6):640-1. PubMed ID: 16943262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay.
    Bonnici A; Ruiner CE; St-Laurent L; Hornstein D
    Ann Pharmacother; 2010 Sep; 44(9):1504-7. PubMed ID: 20628041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome-like, or--dopaminergic malignant syndrome--due to levodopa therapy withdrawal. Clinical features in 11 patients.
    Serrano-Dueñas M
    Parkinsonism Relat Disord; 2003 Jan; 9(3):175-8. PubMed ID: 12573874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient levodopa withdrawal in Parkinson's disease.
    Maesner JE
    Clin Pharm; 1987 Jan; 6(1):22. PubMed ID: 3816104
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome in advanced Parkinson's disease.
    Gordon PH; Frucht SJ
    Mov Disord; 2001 Sep; 16(5):960-2. PubMed ID: 11746631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
    Ward C
    J Neurosci Nurs; 2005 Jun; 37(3):160-2. PubMed ID: 16001822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome. When levodopa withdrawal is the cause.
    Rainer C; Scheinost NA; Lefeber EJ
    Postgrad Med; 1991 Apr; 89(5):175-8, 180. PubMed ID: 2008397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease].
    Yamawaki Y; Ogawa N
    Rinsho Shinkeigaku; 1991 Jan; 31(1):62-7. PubMed ID: 2044308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up.
    Houeto JL; Mesnage V; Welter ML; Mallet L; Agid Y; Bejjani BP
    Neurology; 2003 Jan; 60(1):154-5; author reply 154-5. PubMed ID: 12530402
    [No Abstract]   [Full Text] [Related]  

  • 20. [Malignant-like neuroleptic syndrome: a sign to call attention to].
    Segado Soriano A; García Castaño J; del Toro Cervera J; Muiño Miguez A
    An Med Interna; 1995 Sep; 12(9):466-7. PubMed ID: 8924562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.